314 related articles for article (PubMed ID: 16178785)
1. Amphiphilic transdermal permeation enhancers: structure-activity relationships.
Vávrová K; Zbytovská J; Hrabálek A
Curr Med Chem; 2005; 12(19):2273-91. PubMed ID: 16178785
[TBL] [Abstract][Full Text] [Related]
2. Synthetic ceramide analogues as skin permeation enhancers: structure-activity relationships.
Vávrová K; Hrabálek A; Dolezal P; Sámalová L; Palát K; Zbytovská J; Holas T; Klimentová J
Bioorg Med Chem; 2003 Dec; 11(24):5381-90. PubMed ID: 14642582
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery.
Kanikkannan N; Kandimalla K; Lamba SS; Singh M
Curr Med Chem; 2000 Jun; 7(6):593-608. PubMed ID: 10702628
[TBL] [Abstract][Full Text] [Related]
4. Dodecyl Amino Glucoside Enhances Transdermal and Topical Drug Delivery via Reversible Interaction with Skin Barrier Lipids.
Kopečná M; Macháček M; Prchalová E; Štěpánek P; Drašar P; Kotora M; Vávrová K
Pharm Res; 2017 Mar; 34(3):640-653. PubMed ID: 28070753
[TBL] [Abstract][Full Text] [Related]
5. Amino acid derivatives as transdermal permeation enhancers.
Janůšová B; Skolová B; Tükörová K; Wojnarová L; Simůnek T; Mladěnka P; Filipský T; Ríha M; Roh J; Palát K; Hrabálek A; Vávrová K
J Control Release; 2013 Jan; 165(2):91-100. PubMed ID: 23154194
[TBL] [Abstract][Full Text] [Related]
6. Transdermal delivery of highly lipophilic drugs: in vitro fluxes of antiestrogens, permeation enhancers, and solvents from liquid formulations.
Funke AP; Schiller R; Motzkus HW; Günther C; Müller RH; Lipp R
Pharm Res; 2002 May; 19(5):661-8. PubMed ID: 12069170
[TBL] [Abstract][Full Text] [Related]
7. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
Aboofazeli R; Zia H; Needham TE
Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
[TBL] [Abstract][Full Text] [Related]
8. Alteration of skin hydration and its barrier function by vehicle and permeation enhancers: a study using TGA, FTIR, TEWL and drug permeation as markers.
Shah DK; Khandavilli S; Panchagnula R
Methods Find Exp Clin Pharmacol; 2008 Sep; 30(7):499-512. PubMed ID: 18985178
[TBL] [Abstract][Full Text] [Related]
9. Simplified stratum corneum model membranes for studying the effects of permeation enhancers.
Čuříková BA; Procházková K; Filková B; Diblíková P; Svoboda J; Kováčik A; Vávrová K; Zbytovská J
Int J Pharm; 2017 Dec; 534(1-2):287-296. PubMed ID: 29061325
[TBL] [Abstract][Full Text] [Related]
10. Effects of cinnamene enhancers on transdermal delivery of ligustrazine hydrochloride.
Zhang CF; Yang ZL; Luo JB; Zhu QH; Zhao HN
Eur J Pharm Biopharm; 2007 Sep; 67(2):413-9. PubMed ID: 17459682
[TBL] [Abstract][Full Text] [Related]
11. Effect of borneol on the transdermal permeation of drugs with differing lipophilicity and molecular organization of stratum corneum lipids.
Yi QF; Yan J; Tang SY; Huang H; Kang LY
Drug Dev Ind Pharm; 2016; 42(7):1086-93. PubMed ID: 26635061
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic studies of branched-chain alkanols as skin permeation enhancers.
Chantasart D; Li SK; He N; Warner KS; Prakongpan S; Higuchi WI
J Pharm Sci; 2004 Mar; 93(3):762-79. PubMed ID: 14762914
[TBL] [Abstract][Full Text] [Related]
13. Effects of solvents and penetration enhancers on transdermal delivery of thymoquinone: permeability and skin deposition study.
Haq A; Michniak-Kohn B
Drug Deliv; 2018 Nov; 25(1):1943-1949. PubMed ID: 30463442
[TBL] [Abstract][Full Text] [Related]
14. L-Serine and glycine based ceramide analogues as transdermal permeation enhancers: polar head size and hydrogen bonding.
Vávrová K; Hrabálek A; Dolezal P; Holas T; Zbytovská J
Bioorg Med Chem Lett; 2003 Jul; 13(14):2351-3. PubMed ID: 12824032
[TBL] [Abstract][Full Text] [Related]
15. Infrared spectroscopic study of lipid interaction in stratum corneum treated with transdermal absorption enhancers.
Obata Y; Utsumi S; Watanabe H; Suda M; Tokudome Y; Otsuka M; Takayama K
Int J Pharm; 2010 Apr; 389(1-2):18-23. PubMed ID: 20079819
[TBL] [Abstract][Full Text] [Related]
16. Permeation enhancers in transdermal drug delivery: benefits and limitations.
Kováčik A; Kopečná M; Vávrová K
Expert Opin Drug Deliv; 2020 Feb; 17(2):145-155. PubMed ID: 31910342
[No Abstract] [Full Text] [Related]
17. Investigation of the permeation enhancer strategy on benzoylaconitine transdermal patch: the relationship between transdermal enhancement strength and physicochemical properties of permeation enhancer.
Liu C; Farah N; Weng W; Jiao B; Shen M; Fang L
Eur J Pharm Sci; 2019 Oct; 138():105009. PubMed ID: 31306781
[TBL] [Abstract][Full Text] [Related]
18. Natural products as potential drug permeation enhancer in transdermal drug delivery system.
Patil UK; Saraogi R
Arch Dermatol Res; 2014 Jul; 306(5):419-26. PubMed ID: 24481830
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of skin penetration-enhancing effect by laurocapram.
Sugibayashi K; Nakayama S; Seki T; Hosoya K; Morimoto Y
J Pharm Sci; 1992 Jan; 81(1):58-64. PubMed ID: 1619571
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous penetration modifiers and formulation effects.
Kaushik D; Costache A; Michniak-Kohn B
Int J Pharm; 2010 Feb; 386(1-2):42-51. PubMed ID: 19900521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
